Close

Analyst Ratings for Corcept Therapeutics (CORT) [Neutrals]

CORT Rating Summary

CORT Price Target Summary

* Over Last 12-Mos
  |   Expand Research on CORT
Overall Rating: NEUTRAL   Rating Trend: Down   Avg. $ Target: $35.50 (+36%) * Over Last 12-Mos
Rating Score: 5.3 / 10   Percentile Rank: 55%
Date Firm Analyst Type Rating
(Past)
PT
(Past)
Start $
(End $)
% Chg. Details
8/1/2022 Truist Securities
» Updated 11/8/2022
Gregory Fraser Downgrade Hold
(Buy)
28.00
(30.00)
28.66
(26.10)
-8.93% Details
2/1/2019 B.Riley David Buck Downgrade Neutral
(Buy)
12.00
(N/A)
11.18
(26.10)
133.45% Details
Like CORT Ratings? Also take a look at MFIN, AGFY, RBB, CDNA

CORT Ratings News